Bridgefront Capital’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,521
| Closed | -$286K | – | 785 |
|
|
2024
Q4 | $286K | Buy |
24,521
+9,932
| +68% | +$116K | 0.1% | 375 |
|
|
2024
Q3 | $300K | Buy |
14,589
+5,292
| +57% | +$109K | 0.12% | 315 |
|
|
2024
Q2 | $208K | Buy |
+9,297
| New | +$208K | 0.09% | 405 |
|
|
2021
Q1 | – | Sell |
-4,334
| Closed | -$236K | – | 843 |
|
|
2020
Q4 | $236K | Buy |
+4,334
| New | +$236K | 0.08% | 460 |
|